Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

HLVX

HilleVax (HLVX)

HilleVax Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HLVX
DatumZeitQuelleÜberschriftSymbolFirma
10/06/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
10/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HLVXHilleVax Inc
09/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
09/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/05/202422h05GlobeNewswire Inc.HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
20/03/202421h00GlobeNewswire Inc.HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
13/02/202401h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
05/02/202422h05GlobeNewswire Inc.HilleVax to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:HLVXHilleVax Inc
02/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
26/01/202423h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/01/202413h49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
18/01/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
18/01/202413h00GlobeNewswire Inc.HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
08/01/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
08/01/202413h00GlobeNewswire Inc.HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of ChinaNASDAQ:HLVXHilleVax Inc
04/01/202400h28GlobeNewswire Inc.HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
18/12/202323h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/12/202323h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
08/12/202323h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
05/12/202322h56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
05/12/202322h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
05/12/202322h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
28/11/202303h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
28/11/202303h11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
20/11/202322h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
13/11/202323h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
09/11/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
09/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/11/202322h05GlobeNewswire Inc.HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
 Showing the most relevant articles for your search:NASDAQ:HLVX

Kürzlich von Ihnen besucht

Delayed Upgrade Clock